These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6596653)

  • 1. Effects of intravenous infusions of prostaglandin D2 in man.
    Heavey DJ; Lumley P; Barrow SE; Murphy MB; Humphrey PP; Dollery CT
    Prostaglandins; 1984 Dec; 28(6):755-67. PubMed ID: 6596653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
    Karim SM; Adaikan PG; Lau LC; Tai MY
    Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of prostaglandin D3 and D2 in anesthetized dogs.
    Wendling MG; DuCharme DW
    Prostaglandins; 1981 Aug; 22(2):235-43. PubMed ID: 6945633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation with intravenous and oral administration of a carboprostacyclin analogue, 15-cyclopentyl-omega-pentanor-5(E)-carbacyclin (ONO 41483) in man.
    Adaikan PG; Lau LC; Tai MY; Karim SM
    Prostaglandins Leukot Med; 1983 Jan; 10(1):53-64. PubMed ID: 6338531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a prostaglandin DP-receptor partial agonist (192C86) on platelet aggregation and the cardiovascular system in healthy volunteers.
    Gray SJ; Giles H; Posner J
    Br J Clin Pharmacol; 1992 Oct; 34(4):344-51. PubMed ID: 1457268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a hydantoin prostaglandin analogue, BW245C, during oral dosing in man.
    Al-Sinawi LA; Mekki QA; Hassan S; Hedges A; Burke C; Moody SG; O'Grady J
    Prostaglandins; 1985 Jan; 29(1):99-111. PubMed ID: 3975430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous infusion of prostacyclin (PGI2) in man.
    O'Grady J; Warrington S; Moti MJ; Bunting S; Flower R; Fowle AS; Higgs EA; Moncada S
    Prostaglandins; 1980 Feb; 19(2):319-32. PubMed ID: 6992228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.
    Data JL; Molony BA; Meinzinger MM; Gorman RR
    Circulation; 1981 Jul; 64(1):4-12. PubMed ID: 6263515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
    Miyamori I; Morise T; Yasuhara S; Takeda Y; Koshida H; Takeda R
    Br J Clin Pharmacol; 1985 Dec; 20(6):681-3. PubMed ID: 3912001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance and pharmacology of ciprostene, a stable epoprostenol (prostacyclin) analogue in humans.
    Linet OI; Nishizawa EE; Schaub RG; VanderLugt JT; Greenwald CA
    J Clin Pharmacol; 1986 Feb; 26(2):131-40. PubMed ID: 3005377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB; Miller OV; Spillers C; Gorman RR
    Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of atrial natriuretic factor on platelet function in whole blood ex-vivo in man.
    Lang CC; Lau CS; Belch JJ; Struthers AD
    Eur J Clin Pharmacol; 1990; 39(6):589-91. PubMed ID: 2151320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of single oral dose administration of a hydantoin prostaglandin analogue BW 245C in man.
    Shah A; Pickles H; Joshi M; Webster A; O'Grady J
    Life Sci; 1984 Jun; 34(23):2281-6. PubMed ID: 6727564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of prostaglandin D2 and identification of metabolites in human plasma during intravenous infusion.
    Barrow SE; Heavey DJ; Ennis M; Chappell CG; Blair IA; Dollery CT
    Prostaglandins; 1984 Dec; 28(6):743-54. PubMed ID: 6441188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central cardiovascular and thermal effects of prostaglandin D2 in rats.
    Sirén AL
    Prostaglandins Leukot Med; 1982 Apr; 8(4):349-59. PubMed ID: 6955803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
    Hamid S; Whittle BJ
    Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new stable prostacyclin analogue OP41483 (15-cyclopentyl-omega-pentanor-5(E)-carbacyclin).
    Yui Y; Takatsu Y; Hattori R; Kawai C; Osaki Y; Yohida T
    Jpn Circ J; 1985 Jun; 49(6):571-5. PubMed ID: 3897597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
    Hamid-Bloomfield S; Whittle BJ
    Br J Pharmacol; 1986 Aug; 88(4):931-6. PubMed ID: 3017497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin d2 as a potential antithrombotic agent.
    Nishizawa EE; Miller WL; Gorman RR; Bundy GL; Svensson J; Hamberg M
    Prostaglandins; 1975 Jan; 9(1):109-21. PubMed ID: 806102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.